Emil Aagaard Thomsen

6PUBLICATIONS
38CO-AUTHORS
Innate immunityEpigenetics (incl. genome methylation and epigenomics)Cellular nervous systemMicro- and nanosystemsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 19, 2025
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor.

Bao-Cun Zhang, Alice Pedersen, Line S Reinert

|Aug 14, 2025
Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles.

Sofie Andersen, Jonas Holst Wolff, Thomas Wisbech Skov

|Jul 24, 2024
TMEFF1 is a neuron-specific restriction factor for herpes simplex virus.

Yao Dai, Manja Idorn, Manutea C Serrero

|Sep 07, 2023
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification.

Jakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial

|May 16, 2023
Resistance to vincristine in DLBCL by disruption of p53-induced cell cycle arrest and apoptosis mediated by KIF18B and USP28.

Anne Bruun Rovsing, Emil Aagaard Thomsen, Ian Nielsen

|Aug 06, 2022
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.

Malene Blond Ipsen, Ea Marie Givskov Sørensen, Emil Aagaard Thomsen

Pageof 1

Frequent Collaborators

3 joint publications

Jacob Giehm Mikkelsen

2 joint publications

Manja Idorn

2 joint publications

Ryo Narita

2 joint publications

Bao-Cun Zhang